Overview of Cedon
Quick Facts: Cedon (Cefpodoxime)
| Property | Description |
|---|---|
| Active ingredient | Cefpodoxime proxetil |
| Form | Film-coated tablet, Granules for oral suspension |
| Pharmacological class | Third-generation cephalosporin (Antibiotic) |
| Common use | Systemic bacterial infections |
| Origin | Synthetic beta-lactam derivative |
What Type of Medicine is Cedon? Defining Its Class
Cedon is a prescription-only medication containing the synthetic active substance Cefpodoxime proxetil. Its fundamental classification is that of an antibiotic, which functions by selectively targeting and eliminating bacteria within the body. Specifically, it belongs to the beta-lactam class, categorized as a third-generation cephalosporin. This third-generation classification, widely recognized in clinical practice, allows for a broad spectrum of activity and provides enhanced stability against certain bacterial enzymes compared to older cephalosporin drugs. Cefpodoxime, the active form derived from Cedon, is frequently utilized when treating confirmed or suspected bacterial infections in both adult and pediatric patient groups.
Composition and Available Pharmaceutical Forms
The active ingredient is Cefpodoxime proxetil (INN), a compound classified as an orally active prodrug. This specific formulation is a key differentiating feature, as the administered substance is inactive until it is absorbed from the gastrointestinal tract and then rapidly converted into the microbiologically active agent, Cefpodoxime. This mechanism optimizes the drug’s absorption, ensuring sufficient active medicine reaches the bloodstream to fight the infection. Cedon is provided for oral administration in two primary high-level forms: a film-coated tablet and granules for oral suspension, ensuring suitability across different patient age and compliance requirements.
The General Purpose of This Antibiotic
The overarching general purpose of Cedon is to provide a decisive intervention against systemic bacterial infections by eliminating the microorganisms responsible for the disease. Its therapeutic function relies on a bactericidal action—it directly kills susceptible bacteria by inhibiting the synthesis of the crucial bacterial cell wall. The utility of Cefpodoxime is clinically recognized for countering a wide variety of bacterial pathogens, offering the benefit of resolving the underlying infection and supporting the patient’s recovery.
Regulatory References

